B-Lymphocyte Antigen CD19 (CD19) Antibody

Este producto es parte de CD19 - CD19 molecule
Product Graph
442€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
B-Lymphocyte Antigen CD19 (CD19) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx461463
tested applications
ELISA, FCM

Description

B-Lymphocyte Antigen CD19 (CD19) Antibody is a monoclonal Nanobody expressed in CHO cells for the detection of Human CD19.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
B-Lymphocyte Antigen CD19 (CD19)
Host
CHO cells
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
VHH-8His-Cys-tag
Clone ID
S305
Purity
> 95% (SDS-PAGE)
Purification
Purified by Protein A/G affinity chromatography.
Size 1
100 µg
Size 2
1 mg
Form
Liquid
Tested Applications
ELISA, FCM
Buffer
0.01 M PBS, pH 7.4.
Availability
Shipped within 5-12 working days.
Storage
Store at 4 °C if the entire vial will be used within 1 week. Aliquot and store at -20 °C or -80 °C for long-term storage. Avoid repeated freeze-thaw cycles.
Dry Ice
No
UniProt ID
P15391
Gene ID
930
NCBI Accession
NP_001171569.1
Alias
B4,CVID3,B-lymphocyte antigen CD19,B-lymphocyte surface antigen B4,Differentiation antigen CD19,T-cell surface antigen Leu-12
Background
Antibody anti-CD19
Status
RUO
Note
Concentration: 1 mg/ml - 

Descripción

Related Products

EH4869

Human CD19(Cluster of Differentiation 19) ELISA Kit

Ver Producto
EM0689

Mouse CD19(Cluster of differentiation 19) ELISA Kit

Ver Producto
FNab09868

anti- CD19 antibody

Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.

Ver Producto